Literature DB >> 19955822

Observational studies are complementary to randomized controlled trials.

Diana C Grootendorst1, Kitty J Jager, Carmine Zoccali, Friedo W Dekker.   

Abstract

Randomized controlled trials (RCTs) are considered the gold standard study design to investigate the effect of health interventions, including treatment. However, in some situations, it may be unnecessary, inappropriate, impossible, or inadequate to perform an RCT. In these special situations, well-designed observational studies, including cohort and case-control studies, may provide an alternative to doing nothing in order to obtain estimates of treatment effect. It should be noted that such studies should be performed with caution and correctly. The aims of this review are (1) to explain why RCTs are considered the optimal study design to evaluate treatment effects, (2) to describe the situations in which an RCT is not possible and observational studies are an adequate alternative, and (3) to explain when randomization is not needed and can be approximated in observational studies. Examples from the nephrology literature are used for illustration. Copyright 2009 S. Karger AG, Basel.

Mesh:

Year:  2009        PMID: 19955822     DOI: 10.1159/000262299

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  17 in total

Review 1.  A pathway to improved prospective observational post-authorization safety studies.

Authors:  Victor A Kiri
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

2.  Comparison between treatment effects in a randomised controlled trial and an observational study using propensity scores in primary care.

Authors:  Beth L Stuart; Louise En Grebel; Christopher C Butler; Kerenza Hood; Theo J M Verheij; Paul Little
Journal:  Br J Gen Pract       Date:  2017-07-31       Impact factor: 5.386

3.  A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation.

Authors:  Mahmut Ilker Yilmaz; Alper Sonmez; Mutlu Saglam; Tuncer Cayci; Selim Kilic; Hilmi Umut Unal; Murat Karaman; Hakki Cetinkaya; Tayfun Eyileten; Mahmut Gok; Yusuf Oguz; Abdulgaffar Vural; Francesca Mallamaci; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-26       Impact factor: 8.237

4.  Clinical usefulness of lanthanum carbonate for serum phosphate control in difficult patients.

Authors:  J Almirall; L Betancourt; V Esteve; M P Valenzuela; T López; A Ruiz; J C Martínez-Ocaña; X Calvet
Journal:  Int Urol Nephrol       Date:  2010-11-11       Impact factor: 2.370

5.  [Nothing is more damaging to a new truth than an old error : Conformity of new guidelines on opioid administration for chronic pain with the effect prognosis of the DGSS S3 guidelines LONTS (long-term administration of opioids for non-tumor pain)].

Authors:  H Sorgatz; C Maier
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

6.  A Swedish hip arthroscopy registry: demographics and development.

Authors:  Mikael Sansone; Mattias Ahldén; Pall Jonasson; Christoffer Thomeé; Leif Swärd; Adad Baranto; Jón Karlsson; Roland Thomeé
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-01-25       Impact factor: 4.342

7.  The RISAP-study: a complex intervention in risk communication and shared decision-making in general practice.

Authors:  Pia Kirkegaard; Adrian G K Edwards; Bo Hansen; Mette D Hansen; Morten S A Jensen; Torsten Lauritzen; Mette B Risoer; Janus L Thomsen
Journal:  BMC Fam Pract       Date:  2010-09-22       Impact factor: 2.497

8.  Long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI centre.

Authors:  Hai-Mu Yao; You-Dong Wan; Xiao-Juan Zhang; De-Liang Shen; Jin-Ying Zhang; Ling Li; Luo-Sha Zhao; Tong-Wen Sun
Journal:  BMJ Open       Date:  2014-08-11       Impact factor: 2.692

9.  Comparison of Estimates between Cohort and Case-Control Studies in Meta-Analyses of Therapeutic Interventions: A Meta-Epidemiological Study.

Authors:  Amy Lanza; Philippe Ravaud; Carolina Riveros; Agnes Dechartres
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

Review 10.  Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review.

Authors:  Timor Faber; Philippe Ravaud; Carolina Riveros; Elodie Perrodeau; Agnes Dechartres
Journal:  BMC Med Res Methodol       Date:  2016-03-22       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.